Page 614 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 614

570        sEctiON iii    Psychiatry  ` Psychiatry—Pathology                                                                                                               Psychiatry  ` Psychiatry—Pathology





               Psychoactive drug intoxication and withdrawal
                DrUg                 iNtoXicatioN                              WithDraWal
                Depressants
                                     Nonspecific: mood elevation,  anxiety, sedation,  Nonspecific: anxiety, tremor, seizures,
                                      behavioral disinhibition, respiratory depression.  insomnia.
                Alcohol              Emotional lability, slurred speech, ataxia,          Alcoholic hallucinosis
                                       coma, blackouts. Serum γ-glutamyltransferase         (usually visual)
                                       (GGT)—sensitive indicator of alcohol use. AST     Withdrawal seizures
                                       value is 2× ALT value (“ToAST 2 ALcohol”).  Tremors, insomnia, diaphoresis,  Delirium tremens
                                     Treatment: benzodiazepines.                     agitation, GI upset

                                                                               0  3  6  12  24    36    48         96
                                                                                           Time from last drink (hours)
                Barbiturates         Low safety margin, marked respiratory     Delirium, life-threatening cardiovascular
                                       depression. Treatment: symptom management   collapse.
                                       (eg, assist respiration,  BP).

                Benzodiazepines      Greater safety margin. Ataxia, minor      Sleep disturbance, depression.
                                       respiratory depression. Treatment: flumazenil
                                       (benzodiazepine receptor antagonist, but
                                       rarely used as it can precipitate seizures).
                Opioids              Euphoria, respiratory and CNS depression,   Sweating, dilated pupils, piloerection (“cold
                                       gag reflex, pupillary constriction (pinpoint   turkey”), rhinorrhea, lacrimation, yawning,
                                      pupils), seizures. Most common cause of drug   nausea, stomach cramps, diarrhea (“flu-like”
                                      overdose death. Treatment: naloxone.      symptoms). Treatment: symptom management,
                                                                                methadone, buprenorphine.
                Inhalants            Disinhibition, euphoria, slurred speech,   Irritability, dysphoria, sleep disturbance,
                                       disturbed gait, disorientation, drowsiness.  headache.
                Stimulants
                                     Nonspecific: mood elevation,  appetite,   Nonspecific: post-use “crash,” including
                                       psychomotor agitation, insomnia, cardiac   depression, lethargy,  appetite, sleep
                                       arrhythmias, tachycardia, anxiety.       disturbance, vivid nightmares.
                Amphetamines         Euphoria, grandiosity, pupillary dilation,
                                       prolonged wakefulness, hyperalertness,
                                       hypertension, paranoia, fever, fractured teeth.
                                       Skin excoriations with methamphetamine use.
                                       Severe: cardiac arrest, seizures. Treatment:
                                       benzodiazepines for agitation and seizures.
                Caffeine             Palpitation, agitation, tremor, insomnia.  Headache, difficulty concentrating, flu-like
                                                                                symptoms.
























          FAS1_2019_13-Psych.indd   570                                                                                 11/7/19   5:28 PM
   609   610   611   612   613   614   615   616   617   618   619